Precigen, Inc. Financing cash flow

Financing cash flow of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Financing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Financing cash flow for the quarter ending June 30, 2022 was $-135 Thousand (a -25.41% decrease compared to previous quarter)
  • Year-over-year quarterly Financing cash flow decreased by -168.88%
  • Annual Financing cash flow for 2021 was $121 Million (a 281.18% increase from previous year)
  • Annual Financing cash flow for 2020 was $31.8 Million (a 345.44% increase from previous year)
  • Annual Financing cash flow for 2019 was $7.14 Million (a -97.69% decrease from previous year)
  • Twelve month Financing cash flow ending June 30, 2022 was $-240 Thousand (a 54.84% increase compared to previous quarter)
  • Twelve month trailing Financing cash flow decreased by -100.2% year-over-year
Trailing Financing cash flow for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$-240 Thousand $-155 Thousand $121 Million $121 Million
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Financing cash flow of Precigen, Inc.

Most recent Financing cash flowof PGEN including historical data for past 10 years.

Interactive Chart of Financing cash flow of Precigen, Inc.

Precigen, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.14 $-0.18
2021 $-0.12 $0.2 $-0.05 $121.04 $121.28
2020 $-0.07 $-0.11 $-1.26 $34.15 $31.82
2019 $1.2 $0.05 $-0.03 $6.93 $7.14
2018 $27.25 $193.6 $0.68 $88.26 $309.8
2017 $13.7 $-6.68 $0.41 $-3.15 $5.2
2016 $0.9 $-5.72 $7.29 $9.59 $12.07
2015 $0.24 $213.05 $7.73 $110.66 $331.68
2014 $1.41 $-3.38 $0.76 $25.21 $24.0
2013 $0.47 $169.0 $83.91 $63.07 $316.45
2012 $25.2 $0.2 $50.55 $75.94
2011 $148.11 $148.11

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology